Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Cyclized NDGA modifies dynamic α-synuclein monomers preventing aggregation and toxicity 2019
2019 Genetic defects in mitochondrial dynamics in caenorhabditis elegans impact ultraviolet c radiation- and 6-hydroxydopamine-induced neurodegeneration 2019
2019 Vacuolar protein sorting protein 41 (VPS41) at an intersection of endosomal traffic in neurodegenerative disease 2019
2019 Found in translation: The utility of C. elegans Alpha-Synuclein models of Parkinson’s disease 2019
2019 ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans 2019
2018 Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration 2018
2018 No country for old worms: A systematic review of the application of C. elegans to investigate a bacterial source of environmental neurotoxicity in parkinson’s disease 2018
2018 Correction to: The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity (Molecular Neurobiology, (2018), 55, 9, (7533-7552), 10.1007/s12035-018-0881-7) 2018
2018 The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity 2018
2018 Alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson's disease 2018
2018 Gene-by-environment interactions that disrupt mitochondrial homeostasis cause neurodegeneration in C. elegans Parkinson's models 2018
2017 Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans 2017
2017 Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. Elegans models of parkinson’s disease 2017
2017 NCEH-1 modulates cholesterol metabolism and protects against α-synuclein toxicity in a C. elegans model of Parkinson's disease 2017
2017 Dihydropyrimidine-Thiones and Clioquinol Synergize to Target β-Amyloid Cellular Pathologies through a Metal-Dependent Mechanism 2017
2017 C. elegans as a model system to accelerate discovery for Parkinson disease 2017
2017 Meet our editorial board member 2017
2017 Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration 2017
2016 Chemical compensation of mitochondrial phospholipid depletion in yeast and animal models of Parkinson's disease 2016
2015 A bacterial metabolite induces glutathione-tractable proteostatic damage, proteasomal disturbances, and PINK1-dependent autophagy in C. elegans 2015
2015 Glutaredoxin deficiency exacerbates neurodegeneration in C. Elegans models of Parkinson's disease 2015
2015 Phenazine derivatives cause proteotoxicity and stress in C. elegans 2015
2014 RTCB-1 mediates neuroprotection via XBP-1 mRNA splicing in the unfolded protein response pathway 2014
2014 Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease 2014
2014 Calcineurin determines toxic versus beneficial responses to α-synuclein 2014
2014 The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models 2014
2014 Clioquinol promotes the degradation of metal-dependent amyloid-ß (Aß) oligomers to restore endocytosis and ameliorate Aß toxicity 2014
2014 The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans 2014
2014 TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS 2014
2014 Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events 2014
2014 Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans models of human neurodegenerative diseases 2014
2014 Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model 2014
2013 Lysosomal impairment in Parkinson's disease 2013
2013 Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling 2013
2013 Invertebrate models of dystonia 2013
2013 Yeast reveal a "druggable" Rsp5/Nedd4 network that ameliorates α-Synuclein toxicity in neurons 2013
2012 Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity 2012
2012 A Predictable Worm: Application of Caenorhabditis elegans for Mechanistic Investigation of Movement Disorders 2012
2012 The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response 2012
2012 Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease 2012
2012 Different 8-hydroxyquinolines protect models of TDP-43 protein, α-synuclein, and polyglutamine proteotoxicity through distinct mechanisms 2012
2011 Functional links between Aβ toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast 2011
2011 Methodological strategies to evaluate functional effectors related to parkinson's disease through application of caenorhabditis elegans models 2011
2011 Modeling dopamine neuron degeneration in caenorhabditis elegans 2011
2011 Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models 2011
2011 TorsinA participates in endoplasmic reticulum-associated degradation 2011
2011 Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies 2011
2011 Cell culture to investigate neurotoxicity and neurodegeneration utilizing Caenorhabditis elegans 2011
2011 Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease 2011
2010 The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro 2010
2010 Disinfecting dystonia? Drug discovery using worms identifies an antibiotic as a neuroprotective lead molecule for movement disorders 2010
2010 The early-onset torsion dystonia-associated protein, torsinA, is a homeostatic regulator of endoplasmic reticulum stress response 2010
2010 C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease 2010
2010 Chemical enhancement of torsinA function in cell and animal models of torsion dystonia 2010
2010 Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson's disease models 2010
2010 VPS41, a protein involved in lysosomal trafficking, is protective in Caenorhabditis elegans and mammalian cellular models of Parkinson's disease 2010
2010 Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease 2010
2010 Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction 2010
2009 Pharmacogenetic analysis reveals a post-developmental role for Rac GTPases in Caenorhabditis elegans GABAergic neurotransmission 2009
2009 Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration 2009
2009 α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity 2009
2009 Rapid selection of cyclic peptides that reduce α-synuclein toxicity in yeast and animal models 2009
2009 The microtubule-associated protein, NUD-1, exhibits chaperone activity in vitro 2009
2008 Traversing a wormhole to combat Parkinson's disease 2008
2008 Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease 2008
2008 Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model 2008
2008 The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis 2008
2008 Animal models for drug discovery in dystonia 2008
2008 Application of a C. elegans dopamine neuron degeneration assay for the validation of potential parkinson's disease genes 2008
2008 Generation of stable transgenic C. elegans using microinjection 2008
2008 Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. 2008
2008 Paradigms for pharmacological characterization of C. elegans synaptic transmission mutants 2008
2007 Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation 2007
2006 Genetic interactions among cortical malformation genes that influence susceptibility to convulsions in C. elegans 2006
2006 Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species 2006
2006 α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models 2006
2005 Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans 2005
2004 MEC-2 is recruited to the putative mechanosensory complex in C. elegans touch receptor neurons through its stomatin-like domain 2004
2004 Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans 2004
2004 An animal model to discern torsin function: suppression of protein aggregation in C. elegans. 2004
2004 Using Caenorhabditis elegans to probe toxicity of 1-alkyl-3-methylimidazolium chloride based ionic liquids 2004
2003 Role of NudC, a dynein-associated nuclear movement protein, in mitosis and cytokinesis 2003
2003 Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins 2003
2001 Evolutionarily conserved nuclear migration genes required for early embryonic development in Caenorhabditis elegans 2001
1996 Genetic interactions affecting touch sensitivity in Caenorhabditis elegans 1996

Book

Year Title Altmetric
2009 The nematode, Caenorhabditis elegans, as an emerging model for investigating epilepsy.  Ed. 40.  2009

Chapter

Year Title Altmetric
2014 Use of Caenorhabditis elegans to Model Human Movement Disorders.  97-116. 2014
2005 Use of C. elegans to model human movement disorders.  111-126. 2005

Full Name

  • Guy Caldwell